Recombinant Prosaposin antibody (AA 200-400)
Quick Overview for Recombinant Prosaposin antibody (AA 200-400) (ABIN7872037)
Target
See all Prosaposin (PSAP) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 200-400
-
Purpose
- PSAP Antibody / ACP3 / Prostate Specific Acid Phosphatase
-
Purification
- Protein A/G affinity
-
Immunogen
- A recombinant partial protein sequence (within amino acids 200-400) from the human protein was used as the immunogen for the PSAP antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- Optimal dilution of the PSAP antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the PSAP antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Prosaposin (PSAP)
-
Alternative Name
- PSAP
-
Background
- Prostatic Acid Phosphatase (PSAP or PAP) is a member of the histidine acid phosphatase family. It is a non-specific phosphatase that is capable of dephosphorylating tyrosine residues as well as phospholipids under mildly acidic conditions. Prostatic specific acid phosphatase (PSAP) is involved in prostate epithelial differentiation. It is highly expressed in prostate, primary and metastatic carcinoma of the prostate. This marker may be helpful in pinpointing the site of origin in cases of metastatic carcinoma of the prostate, and is considered a more sensitive marker than PSA.
-
UniProt
- P15309
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-